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 Since the declaration of COVID-19 pandemic by WHO on 13 March2020, 
over 210 countries / territories have had active cases and 1/3rd of the 
world’s population have been on complete lockdown or partial 
restriction. Main route of transmission of COVID-19 is through droplets 
like most communicable respiratory illnesses followed by infected 
surfaces. Public measures like wearing masks, social distancing, hand 
washing and other respiratory hygiene are being followed in 
unprecedented level and people are tested rapidly if they show 
symptoms of the disease such as fever, cough, fatigue, myalgia and 
dyspnea. These symptoms are similar to other respiratory diseases such 
as common flu, influenza, pneumonia and Tuberculosis. The preventive 
measures are also effective in these diseases. In Wuhan, China the 
lockdown lasted for 76 days and seems to follow similar course in other 
countries. The air pollution and travel has also decreased which will 
further decrease transmission of respiratory illnesses. These behavioral 
changes can get embedded into human cultures and play a vital role to 
decrease incidence of other respiratory illnesses. To measure the impact, 
we need to be observant and carry time series analysis of the pre and 
post pandemic data. With proper strategies this could be utilized as an 
opportunity to reduce burden of other respiratory communicable 
disease. 
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The COVID-19 (corona virus disease 2019) is 
caused by severe acute respiratory syndrome 
corona virus 2 (SARS-CoV-2). This virus 
belongs to the corona virus family which has 
had outbreaks in the past, namely MERS 
(Middle East Respiratory Syndrome) and 
SARS.1 As of 19 April 2020 there were 
2,359,346 people diagnosed with COVID-19, 
161,951 deaths and 606,705 had recovered 
from the illness.2 
 
The most common symptoms at onset of 
illness in descending order are fever, fatigue, 
dry cough, anorexia, myalgias, dyspnea and 
sputum production.1 These symptoms are 
similar to that of many febrile illnesses and 
other causes of respiratory infection which 
makes it hard to diagnose COVID-19 based 
entirely upon clinical findings. Patients with 
history of travel to places with outbreaks and 
contact with positive case within 14 days are 
prioritized for testing.3 The mode of 
transmission of COVID-19 is mostly through 
droplets (person to person) and by contact 
from infected surfaces.1 Other respiratory 
infection like Influenza and tuberculosis (TB) 
are mainly transmitted by droplets.4 Influenza 
has shorter incubation (median 3 days) period 
than COVID-19 (5-6 days), whereas, TB has 
longer and variable incubation period since 
latent TB can take months to activate.4,5 
 
One infected person on average reproduces 
the infection in about 2-2.5 people which is 
higher than influenza.4 However there are 
incidences like case 31 in South Korea where 
one individual is responsible to transmit the 
disease to a large number of people. 
Individuals with active TB can infect 5-15 
people in a year.5 There is seasonality of 
influenza but not that of TB. Seasonal 
variability of COVID-19 is yet to be fully 
understood. In Influenza infection children 
play a vital role in transmission in the 
community. Children and teenagers are 
relatively less affected by COVID-19 and are 
less serious than older age group.4 Most of 
the TB patients are adults, it also affects a 
large number of children and people who are 
immune-compromised.5 
 
Many drugs are under clinical trial and 
vaccines in development.4 This means that the 
fight against COVID-19 is mostly preventive 
for the uninfected and supportive for those 
who have the disease. After WHO declaration 
of pandemic on 13 March 2020, by 19 April 
2020, more than 210 countries and/or 
territories have had active cases of COVID-19, 
affecting a third of the world’s population, 
requiring lockdown/restriction.7 In Wuhan, 
the epicenter of pandemic, the lockdown 
lasted for 76 days and other countries are 
following similar course.8 
 
Following recommendations have been issued 
by WHO to combat the COVID-19 infection 
and mitigate transmission of virus.9,10 
 
Who recommendation to the general public9 
1. Social distancing, 
2. Washing hand frequently, 
3. Avoid touching mouth and eyes, 
4. Practice good respiratory hygiene, 
5. Seek medical care early if you have fever, 
cough and or difficulty breathing. 
 
Who recommendation for Health care 
providers10 
1. Ensuring triage, early recognition, and 
source control (isolating patients with 
suspected COVID-19)- have high level of 
suspicion, 
2. Applying standard precautions for all 
patients, 
3. Implementing empiric additional 
precautions (droplet and contact) for 
suspected cases of COVID-19, 
4.  Implementing administrative controls, 
5.  Using environmental and engineering 
controls. 
 
These measures have shown to be useful in 
countries like China and South Korea, and the 
world is following suit. These messages of 
public awareness have been circulated 
throughout the world through different 
multimedia outlets and also through active 
participation of public and influential people 
around the globe. The primary target of this is 
to prevent spread of COVID-19 but these 
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the droplet infection and disease related to 
hand hygiene and contaminated surfaces. 
There is also huge improvement in the air 
quality around the world with decrease in 
pollutant due to lockdown, decreased 
industries, airplane travels and vehicles. 
Decrease in air pollution also reduces non 
communicable illnesses such as heart disease, 
stroke, COPD, asthma, and Lung cancer and 
communicable disease such as pneumonia. 
Further there is reduction in number of 
domestic and international flights, which will 
decrease cross border transmission of 
disease. The Air Quality Index (AQI) needs 
close observation as the world starts to 
resumes its activities. 
 
Way forward- Hypothetically, such strategies 
and practices, like face mask, social 
distancing, and respiratory hygiene along with 
the lockdown will not only reduce the 
transmission of COVID-19 but also decrease 
the incidence of other respiratory disease and 
give better fighting opportunities to programs 
for elimination and eradication of TB, control 
of Influenza infection and Community 
Acquired Pneumonias. It is very plausible for 
this knowledge being carried long after the 
COVID-19 situation is under control as there’s 
a certain amount of phobia and concern 
regarding self-protection from the illness and 
people will continue following some of the 
etiquettes. This can be supported by the fact 
that wearing mask or covering faces with 
clothes got embedded into Asian culture 
especially in Japan after the Spanish flu of 
1918 and global flu epidemic in 1934 after 
which people began wearing mask regularly in 
winter which is prevalent till this date.11 On 
the contrary WHO puts forward concern that 
due to the social stigma of COVID-19 people 
with undiagnosed pulmonary TB may not be 
willing to seek medical care because of similar 
symptoms. This can increase the exposure to 
family members if precautions are not taken 
however the risk of exposure to a larger 
population is markedly reduced. This might 
not be true, rather have an opposite effect, 
where symptomatic patients go for checkup 
early and hence leading to early diagnosis. 
People who have concomitant TB infection 
with COVID- 19 might only be diagnosed for 
later which will delay diagnosis and increase 
mortality and morbidity. The framework of 
contact tracing and testing can be utilized to 
fight against Influenza and Tuberculosis too in 
the future.  
 
In conclusion, for measuring the actual effect 
of COVID-19 public health strategies, we 
should conduct time series analysis to look at 
the incidence of the disease like TB and 
influenza in the coming years and compare it 
to previous years keeping in mind the usual 
rate of reduction or increase in these cases, 
natural variation and advent of other 
interventions that are put in place to increase 
diagnosis and reduce cases. According to 2018 
National Tuberculosis report there were  
32,474 new cases in Nepal and 10% of the 
cases were from Kathmandu district  alone.12 
We can compare incidence and infectivity of 
disease by cities, regions and see if the 
burden of disease shifts from one geographic 
location to other. We can also see if there’s 
change in dynamic of drug resistant TB and 
strains of Influenza. We can also compare the 
cross-infection to family members before and 
after the pandemic. This pandemic has 
potential to shape the human civilization with 
apocalyptic threats and will have long term 
impact in the course of diseases that we 
suffer from. With proper strategies the 
current COVID-19 situation could be utilized 
as an opportunity to reduce burden of other 
respiratory communicable diseases, like TB, 
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